Chemren Bio-Engineering Co., Ltd.

中文版

ENGLISH

News

New inhibitors-GSK2646264A

Inhibitor:LX4211

chemrenblock BioScience

WELCOME TO OUR STAND: E5A51 CP

Tel: 0519-85788828
Fax: 0519-89960117
Mobile: 13775037613
E-mail: sales@chemrenpharm.com
Add: 169 Qingliang Road, Changzhou, Jiangsu,China
QQ: 2500035664

Products > Aurora/Ksp > Aurora > JNJ-7706621

Product name : JNJ-7706621

Item : CR1017

CAS : 443797-96-4

Enlarge Image

Back

←[Previous Product] [Next Product]→

Details:

Description of:JNJ-7706621
JNJ-7706621 slowed the growth of cells and at higher concentrations induced cytotoxicity. Inhibition of CDK1 kinase activity, altered CDK1 phosphorylation status,and interference with downstream substrates such as retinoblastoma were also shown in human tumor cells following drug treatment.
JNJ-7706621 is a novel cell cycle inhibitor that showed potentv inhibition of several cyclin-dependent kinases (CDK) and Aurora kinases and selectively blocked proliferation of tumor cells of various origins but was about 10-fold less effective at inhibiting normal human cell growth in vitro.

Theoretical analysis:JNJ-7706621
M.Wt: 394.36
Formula: C₁₅H₁₂F₂N₆O₃S
Solubility: DMSO
Purity: >99.5%
CAS No: 443797-96-4
Storage: at -20℃ 2 years

Availability and price:
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to : sales@chemrenpharm.com

Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days

Related Products :

Barasertib(AZD1152-HQPA)

AT9283

CYC116

MLN8237(Alisertib)